Similar computations for TGFBR1*6A allele indicate that for a fifteen percent increment in the risk for breast cancer [10] due to presence of this allele, nearly twenty thousand patients and controls would be needed whereas, to determine its effect recessively, over a million subjects would be needed. This evidence concerns the gene TGFBR1 and breast carcinoma.